newbridge
Exclusive: Pfizer, Allergan CEOs agree on combined company roles – sources
November 21, 2015 by elegant · Leave a Comment
Pfizer Inc and Allergan Inc chief executives have agreed on the roles they would assume in a combined company, removing one of the last hurdles to the largest ever healthcare merger, people familiar with the matter said. Pfizer CEO Ian Read will be CEO of the combined company, while Allergan CEO Brent Saunders will have another very senior role, the people said on Friday, without providing more details. Pfizer and Allergan declined to comment.
Original post:
Exclusive: Pfizer, Allergan CEOs agree on combined company roles – sources
newbridge
Exclusive: Pfizer negotiating 2-3 percent Allergan break-up fee – sources
November 19, 2015 by elegant · Leave a Comment
A break-up fee of that amount, to be paid by Pfizer if it were to walk away from the Allergan deal, would show confidence that the regulatory risk to the merger does not pose an existential threat, despite the U.S. Treasury planning this week to tighten the rules on corporate tax inversions, a key aspect of their plan. The break-up fee…
More here:
Exclusive: Pfizer negotiating 2-3 percent Allergan break-up fee – sources